Medical Condition News

RSS

Specific fruit choices boost flavanols for a healthier heart

Including blueberries, plums, blackberries, broad beans or cherries (washed down with green tea) in your five-a-day may be the best way to a healthier heart, new research suggests.

8 Jun 2026

Weight loss drugs linked to lower risk of alcohol, opioid, nicotine and cocaine use disorders

A new study led by researchers at The University of Texas at El Paso found that use of weight loss drugs like Ozempic and other GLP-1s is associated with a lower risk of developing alcohol, opioid, nicotine and cocaine use disorders.

8 Jun 2026

Diabetes drug dramatically lowers heart failure risk in genetic carriers

Rare genetic variants known to cause cardiomyopathy, an inherited cause of a weak heart, can increase the risk of patients developing heart failure.

8 Jun 2026

Acupuncture improves stroke recovery and reshapes brain networks

Acupuncture shows promise for stroke recovery, promoting neuroplasticity and motor function improvements, according to findings from a randomized MRI trial.

8 Jun 2026

NHS online diabetes program improves blood sugar and pressure

NHS England's Healthy Living program offers modest diabetes improvements; addressing engagement and access could enhance its public health effectiveness.

8 Jun 2026

Living in a rural area may worsen epilepsy outcomes

A study reveals rural Americans with epilepsy face higher mortality and diagnostic gaps, emphasizing the need for improved healthcare access and resources.

8 Jun 2026

DNA study links BRCA genes to aggressive early-onset breast cancer in black women

Black women experience disproportionately elevated risks of developing and dying from early-onset breast cancer. New research published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society, reveals the genes that are most likely to be mutated to contribute to these increased risks.

8 Jun 2026

Researchers develop compound 10 to slow Alzheimer's disease progression

Researchers from ETH Zurich have developed an active ingredient that slows down the progression of typical Alzheimer’s symptoms in mice. This new substance protects nerve cells and could in future alleviate the suffering of Alzheimer’s patients. The active ingredient also shows anti-aging effects.

8 Jun 2026

Weight loss medications show promise in preventing obesity-related cancers

A study of more than 229,000 obese adults without diabetes in the United States has shown that weight loss drugs are associated with a decreased risk of obesity-related cancers.

7 Jun 2026

GLP-1 therapies linked to fewer complications in adults with both obesity and autoimmune disease

Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) medication had lower rates of emergency department visits and were less likely to experience serious cardiac events, such as stroke, pulmonary embolism or death when compared to similar adults who were not taking these medications, according to new research published today in the Journal of the American Heart Association, an open-access, peer-reviewed journal of the American Heart Association.

7 Jun 2026

Infections pose major but overlooked risks in people with diabetes

Infections should be considered a "health hazard" in people living with diabetes, with experts warning that current clinical guidelines fail to reflect a substantial but under-recognized burden of illness, hospitalization and death.

7 Jun 2026

Microbially modified bile acids influence sleep apnea outcomes

Studies in mice reveal a new target for potentially treating and preventing life-threatening cardiovascular complications in the millions of patients with sleep apnea worldwide.

7 Jun 2026

Patient organizations strengthen support for people with rheumatic diseases

Rheumatic and musculoskeletal diseases (RMD) are chronic, often lifelong conditions. EULAR - The European Alliance of Associations for Rheumatology - works with the network of national organizations of People with Arthritis/Rheumatism in Europe (PARE) to ensure the voices of people with RMD are heard and have influence among decision makers - creating powerful alliances that make a real difference to lives.

7 Jun 2026

New findings highlight risks and therapeutic targets in systemic sclerosis

Systemic sclerosis is a rare connective tissue disorder characterised by autoimmune features with vascular manifestations, causing fibrosis of the skin and internal organs.

7 Jun 2026

AI predicts meningioma recurrence from routine pathology slides

Mayo Clinic researchers and collaborators have shown that artificial intelligence (AI) can analyze routine pathology slides to help classify meningiomas, the most common primary brain tumor in adults, and predict a patient's risk of tumor recurrence.

7 Jun 2026

Researchers identify hidden self-harm histories using machine learning

Important mental health history is often present in medical records but hard to find, especially when it is missing from the diagnosis codes that clinicians, researchers and health systems use to search and count conditions.

5 Jun 2026

Researchers challenge the traditional understanding of how histone deacetylase inhibitors function

Researchers at Baylor College of Medicine and collaborating institutions are challenging the traditional understanding of how cancer drugs called histone deacetylase (HDAC) inhibitors function.

5 Jun 2026

Integrated care reduces hospital visits for adults with disabilities

University of Cincinnati and Ohio State University researchers have found that adults with developmental disabilities who have integrated care were less likely to go to the emergency room or be hospitalized than others who were not.

5 Jun 2026

Anti-aging herbal extract shows promise against chronic renal failure

Announcing a new publication for Acta Materia Medica journal. Chronic renal failure (CRF) is a progressive disease characterized by a sustained loss of kidney function, for which current therapies remain insufficient.

5 Jun 2026

New artificial intelligence tool helps clinicians distinguish between dementia types

Alzheimer's disease and related dementias are expected to more than double by 2060. As June marks Alzheimer's and Brain Awareness Month, three University of Florida researchers are working to improve clinicians' ability to distinguish between these diseases - a critical step toward earlier diagnosis and better outcomes.

5 Jun 2026